2023
DOI: 10.1016/j.pec.2022.107618
|View full text |Cite
|
Sign up to set email alerts
|

Development of an intervention aimed at the prevention and treatment of chronic pain in breast cancer survivors: An intervention mapping approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 81 publications
(119 reference statements)
2
1
0
Order By: Relevance
“…The results of this machine learning clustering align with previous studies, underlining that these factors significantly impact the risk of lymphedema development [10,33,68,69]. Thus, recent research emphasizes that precise identifications of individual risk factors should be integrated into routine clinical practice to optimize a patient-centered approach targeting BCRL prevention [18]. In contrast, significant differences in terms of BMI were identified only in the BCRL patients, suggesting that the machine learning model might consider the body composition in the patient's clusterization less important.…”
Section: Discussionsupporting
confidence: 80%
See 2 more Smart Citations
“…The results of this machine learning clustering align with previous studies, underlining that these factors significantly impact the risk of lymphedema development [10,33,68,69]. Thus, recent research emphasizes that precise identifications of individual risk factors should be integrated into routine clinical practice to optimize a patient-centered approach targeting BCRL prevention [18]. In contrast, significant differences in terms of BMI were identified only in the BCRL patients, suggesting that the machine learning model might consider the body composition in the patient's clusterization less important.…”
Section: Discussionsupporting
confidence: 80%
“…In another work [10], LVI was described as an indicator of BCRL. The number of lymph nodes with metastasis (NR METASTATIC LN) was already identified as a highly influential factor in BCRL onset [18,52], together with weight variations and obesity measured by BMI [53,54]. Evidence that secondary lymphedema is aggravated by hormone therapy was argued in [55]; indeed, during the present investigation, HR DRUG resulted in another distinguishing factor between patients of the two clusters.…”
Section: Discussionsupporting
confidence: 48%
See 1 more Smart Citation